RELORN
Live / Applied — Fourth extension granted (statement of use) (as of 03 Sept 2025)
What this means for you
Not registered yet, but its 08 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97786502
- Mark type
- Stylized text
- Filed
- 08 Feb 2023
- Published for opposition
- 01 Aug 2023
- Attorney of record
- Eric Stenshoel
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for pain relief and fever reduction
Owner
- Unipharm, Inc., New York, NY, US
- Unipharm, Inc., New York, NY, US
Prosecution history
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2025 — SOU EXTENSION 4 GRANTED
- 03 Sept 2025 — SOU EXTENSION 4 FILED
- 03 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Mar 2025 — SOU EXTENSION 3 GRANTED
- 25 Mar 2025 — SOU EXTENSION 3 FILED
- 25 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Sept 2024 — SOU EXTENSION 2 GRANTED
- 23 Sept 2024 — SOU EXTENSION 2 FILED
- 23 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 09 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2024 — SOU EXTENSION 1 GRANTED
- 26 Mar 2024 — SOU EXTENSION 1 FILED